Warning letter
Agropharma Laboratories, Inc.: warning letter of Mar 25, 2022
FDA warning letter 623475 · Office of Pharmaceutical Quality Operations, Division II
Key facts
| Reference number | 623475 |
|---|---|
| Company | Agropharma Laboratories, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Mar 25, 2022 |
| Posted date | Mar 29, 2022 |
| Issuing office | Office of Pharmaceutical Quality Operations, Division II |
| Product type | Drugs |
| CFR sections cited | 211.165(a), 211.22, 211.34, 211.22(d), 211.56(a), 211.84(d)(1), 211.100(a), 211.166(a), 211.180(e) |
| Inspection city | Salinas |
| Inspection ZIP | 00751 |
| Inspection start date | Oct 21, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: